Frederick J. Derosier

909 total citations
15 papers, 692 citations indexed

About

Frederick J. Derosier is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Frederick J. Derosier has authored 15 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Psychiatry and Mental health, 6 papers in Pathology and Forensic Medicine and 5 papers in Physiology. Recurrent topics in Frederick J. Derosier's work include Migraine and Headache Studies (11 papers), Sympathectomy and Hyperhidrosis Treatments (5 papers) and Menstrual Health and Disorders (4 papers). Frederick J. Derosier is often cited by papers focused on Migraine and Headache Studies (11 papers), Sympathectomy and Hyperhidrosis Treatments (5 papers) and Menstrual Health and Disorders (4 papers). Frederick J. Derosier collaborates with scholars based in United States, United Kingdom and Serbia. Frederick J. Derosier's co-authors include Per Soelberg Sørensen, Richard Grove, Massimo Filippi, Eva Havrdová, Steen Lisby, Jelena Drulović, Susan A. McDonald, Roger Cady, Shelly E. Lener and J. D. White and has published in prestigious journals such as Neurology, PEDIATRICS and Obstetrics and Gynecology.

In The Last Decade

Frederick J. Derosier

15 papers receiving 668 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Frederick J. Derosier United States 12 433 253 208 137 122 15 692
Stephanie Knippenberg Netherlands 12 411 0.9× 67 0.3× 370 1.8× 32 0.2× 42 0.3× 17 754
Dirk Pleimes Germany 11 496 1.1× 69 0.3× 165 0.8× 34 0.2× 105 0.9× 28 659
M. Bogdanow Germany 10 116 0.3× 28 0.1× 116 0.6× 80 0.6× 55 0.5× 16 560
Marta Ponzano Italy 12 151 0.3× 87 0.3× 24 0.1× 35 0.3× 65 0.5× 62 436
Ghaniah Hassan‐Smith United Kingdom 11 152 0.4× 70 0.3× 60 0.3× 26 0.2× 596 4.9× 14 817
Xiaorong Shao United States 13 297 0.7× 50 0.2× 144 0.7× 25 0.2× 33 0.3× 24 639
Bernice Kuca United States 8 139 0.3× 196 0.8× 65 0.3× 137 1.0× 16 0.1× 10 523
Amer Awad United States 7 285 0.7× 27 0.1× 81 0.4× 24 0.2× 127 1.0× 14 430
Graziella Callari Italy 12 169 0.4× 34 0.1× 73 0.4× 55 0.4× 242 2.0× 18 472
Astrid Edland Norway 12 289 0.7× 123 0.5× 50 0.2× 14 0.1× 118 1.0× 16 509

Countries citing papers authored by Frederick J. Derosier

Since Specialization
Citations

This map shows the geographic impact of Frederick J. Derosier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Frederick J. Derosier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Frederick J. Derosier more than expected).

Fields of papers citing papers by Frederick J. Derosier

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Frederick J. Derosier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Frederick J. Derosier. The network helps show where Frederick J. Derosier may publish in the future.

Co-authorship network of co-authors of Frederick J. Derosier

This figure shows the co-authorship network connecting the top 25 collaborators of Frederick J. Derosier. A scholar is included among the top collaborators of Frederick J. Derosier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Frederick J. Derosier. Frederick J. Derosier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Bhattacharjee, Gourab, Alexey S. Revenko, Thomas A. Zanardi, et al.. (2019). IONIS-PKK Rx a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production. Nucleic Acid Therapeutics. 29(2). 82–91. 28 indexed citations
2.
Bar‐Or, Amit, Richard Grove, Daren Austin, et al.. (2018). Subcutaneous ofatumumab in patients with relapsing-remitting multiple sclerosis. Neurology. 90(20). e1805–e1814. 154 indexed citations
3.
Mignon, Laurence, Daniel A. Norris, Kathie M. Bishop, et al.. (2016). ISIS-DMPKRx in Healthy Volunteers: A Placebo-controlled, Randomized, Single Ascending-Dose Phase 1 Study (P3.166). Neurology. 86(16_supplement). 6 indexed citations
4.
Martin, Vincent T., Michael P. Diamond, Lisa K. Mannix, et al.. (2014). Relief of Menstrual Symptoms and Migraine with a Single-Tablet Formulation of Sumatriptan and Naproxen Sodium. Journal of Women s Health. 23(5). 389–396. 16 indexed citations
5.
Sørensen, Per Soelberg, Steen Lisby, Richard Grove, et al.. (2014). Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis. Neurology. 82(7). 573–581. 218 indexed citations
6.
Silberstein, Stephen D., Susan A. McDonald, Jerome Goldstein, et al.. (2013). Sumatriptan/naproxen sodium for the acute treatment of probable migraine without aura: A randomized study. Cephalalgia. 34(4). 268–279. 16 indexed citations
7.
Derosier, Frederick J., Donald W. Lewis, Andrew D. Hershey, et al.. (2012). Randomized Trial of Sumatriptan and Naproxen Sodium Combination in Adolescent Migraine. PEDIATRICS. 129(6). e1411–e1420. 36 indexed citations
8.
Derosier, Frederick J., Fred D. Sheftell, Stephen D. Silberstein, et al.. (2011). Sumatriptan‐Naproxen and Butalbital: A Double‐Blind, Placebo‐Controlled Crossover Study. Headache The Journal of Head and Face Pain. 52(4). 530–543. 20 indexed citations
9.
McDonald, Susan A., Andrew D. Hershey, Eric Pearlman, et al.. (2011). Long‐Term Evaluation of Sumatriptan and Naproxen Sodium for the Acute Treatment of Migraine in Adolescents. Headache The Journal of Head and Face Pain. 51(9). 1374–1387. 30 indexed citations
10.
White, William B., et al.. (2011). Evaluation of the Migraine Treatment Sumatriptan/Naproxen Sodium on Blood Pressure Following Long-Term Administration. Journal of Clinical Hypertension. 13(12). 910–916. 8 indexed citations
11.
Cady, Roger, Merle L. Diamond, Michael P. Diamond, et al.. (2011). Sumatriptan–Naproxen Sodium for Menstrual Migraine and Dysmenorrhea: Satisfaction, Productivity, and Functional Disability Outcomes. Headache The Journal of Head and Face Pain. 51(5). 664–673. 24 indexed citations
12.
Durham, Paul L., Carrie V. Vause, Frederick J. Derosier, et al.. (2010). Changes in Salivary Prostaglandin Levels During Menstrual Migraine With Associated Dysmenorrhea. Headache The Journal of Head and Face Pain. 50(5). 844–851. 32 indexed citations
13.
Mathew, Ninan T., Stephen H. Landy, Stuart R. Stark, et al.. (2009). Fixed‐Dose Sumatriptan and Naproxen in Poor Responders to Triptans With a Short Half‐Life. Headache The Journal of Head and Face Pain. 49(7). 971–982. 38 indexed citations
14.
Mannix, Lisa K., Vincent T. Martin, Roger Cady, et al.. (2009). Combination Treatment for Menstrual Migraine and Dysmenorrhea Using Sumatriptan–Naproxen. Obstetrics and Gynecology. 114(1). 106–113. 64 indexed citations
15.
Mannix, Lisa K., Vincent T. Martin, Roger Cady, et al.. (2009). Combination Treatment for Menstrual Migraine and Dysmenorrhea Using Sumatriptan-Naproxen. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026